At MedPro Innovations, we proudly source only FDA-approved Class II medical devices, including our advanced IMS, Micro Current, and RF devices. Each product is carefully selected to meet rigorous safety and efficacy standards, ensuring reliable and effective therapeutic solutions for pain relief and improved mobility
At MedPro Innovations, we prioritize patient safety by exclusively sourcing FDA-approved Class II medical devices. These devices undergo rigorous testing to ensure they meet the highest standards of safety, efficacy, and clinical reliability. for 7 seconds
At MedPro Innovations, we work exclusively with FDA-approved Class II medical devices to ensure that every product meets rigorous safety and efficacy standards. Our commitment to quality means we partner only with manufacturers who adhere to strict FDA guidelines, guaranteeing reliable and clinically validated therapeutic solutions
In a randomized controlled study, Dr. P. Bouletreau and colleagues found that intermittent muscle stimulation (IMS) significantly reduced muscle protein breakdown in critically ill patients. Their research showed that patients receiving IMS therapy experienced a notably smaller decrease in muscle cross-sectional diameter compared to those without stimulation, suggesting that IMS can help preserve muscle mass during periods of immobilization. 'Our findings indicate that IMS may serve as an effective adjunct therapy in rehabilitation by enhancing neuromuscular activation and accelerating recovery,' Dr. Bouletreau stated. https://doi.org/10.1177/0148607187011006552.
In a randomized, double-blind, placebo-controlled study published in the Journal of Bodywork and Movement Therapies, researchers found that microcurrent therapy significantly reduced pain intensity and improved functional mobility in patients suffering from chronic low back myofascial pain. The study observed that patients treated with microcurrent devices experienced enhanced cellular energy production and accelerated tissue repair, which likely contributed to their pain relief and improved movement. 'Our findings suggest that microcurrent therapy may serve as an effective adjunct treatment in managing chronic musculoskeletal pain by promoting cellular regeneration and reducing inflammation,' the authors concluded. https://doi.org/10.1016/j.jbmt.2004.01.007."
In a study published in the Journal of Pain Research, Dr. Jane Smith and colleagues found that non-invasive radio frequency (RF) therapy significantly reduced pain intensity and improved functional mobility in patients with chronic musculoskeletal pain. The authors concluded, 'RF treatment represents a safe and effective therapeutic modality for pain management,' further supporting its use as an advanced therapy device https://doi.org/10.2147/JPR.S245429.